KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Alnylam Pharmaceuticals posted quarterly Debt Ratio of 0.03 for Q3 2025, down 5.5% on a QoQ basis from 0.03 in Q2 2025.

Alnylam Pharmaceuticals (ALNY) has 8 years of Debt Ratio data on file, last reported at 0.03 in Q3 2025.

  • For the quarter ending Q3 2025, Debt Ratio changed N/A year-over-year to 0.03; the trailing twelve-month figure through Sep 2025 stood at 0.03 (changed N/A YoY), and the FY2024 full-year result was 0.02, changed N/A from the prior year.
  • Debt Ratio for Q3 2025 stood at 0.03, down from 0.03 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.19 in Q4 2021 and bottomed at 0.02 in Q4 2024.
  • The 3-year median for Debt Ratio is 0.03 (2025), against an average of 0.06.
  • Peak annual rise in Debt Ratio reached 230.35% in 2021, while the deepest fall reached 230.35% in 2021.
  • A 3-year view of Debt Ratio shows it stood at 0.19 in 2021, then sank by 88.07% to 0.02 in 2024, then gained by 13.01% to 0.03 in 2025.
  • The last three Debt Ratio figures came in at 0.03 (Q3 2025), 0.03 (Q2 2025), and 0.03 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.03
Dec 31, 2024 0.02
Dec 31, 2021 0.19
Dec 31, 2020 0.06
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.02
Sep 30, 2018 0.02
Jun 30, 2018 0.02
Mar 31, 2018 0.02
Dec 31, 2017 0.02
Sep 30, 2017 0.11
Jun 30, 2017 0.10
Mar 31, 2017 0.13
Dec 31, 2016 0.12
Sep 30, 2016 0.11
Jun 30, 2016 0.11